Novel guanidinyl-substituted hydroxy6-phenylphenenthridines as effective phosphodiesterase (PDE) 4 inhibitors
Details for Australian Patent Application No. 2005212857 (hide)
International Classifications
Event Publications
5 October 2006 PCT application entered the National Phase
PCT publication WO2005/077906 Priority application(s): WO2005/077906
22 November 2007 Change of Name(s) of Applicant(s), Section 104
ALTANA Pharma AG The name of the applicant has been changed to Nycomed GmbH
28 April 2011 Application Accepted
Published as AU-B-2005212857
25 August 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005212856-1,2,4-triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser